Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The European Respiratory Journal|March 7, 2020
Mepolizumab effectiveness and identification of super-responders in severe asthmaErin S Harvey, David Langton, Constance Katelaris, et al.
Respiratory Medicine|September 5, 2025
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab RegistryErin S Harvey, Yuto Hamada, Sarah A Hiles, et al.
Allergy|August 26, 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patientsDennis Thomas, Vanessa M McDonald, Sean Stevens, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 5, 2021
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab RegistryDennis Thomas, Erin S Harvey, Vanessa M McDonald, et al.
Respirology (Carlton, Vic.)|September 20, 2018
Treatable traits can be identified in a severe asthma registry and predict future exacerbationsVanessa M McDonald, Sarah A Hiles, Krystelle Godbout, et al.
Allergy|June 26, 2024
Real-world biologics response and super-response in the International Severe Asthma Registry cohortEve Denton, Mark Hew, Matthew J Peters, et al.
Frontiers in Immunology|May 7, 2024
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthmaCeleste M Porsbjerg, John Townend, Celine Bergeron, et al.
Pageof 3